Journal of Clinical Oncology

Still Lost in Transition? A 20-Year Reflection on Cancer Survivorship Care

M Michael Jefford (Australian Cancer Survivorship Centre, Centre for Health Services Research in Cancer, and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia) R Raymond Javan Chan (Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, SA, Australia) I Ines Vaz-Luis (Cancer Survivorship, INSERM Unité 981, Institut Gustave Roussy, Villejuif, France) L Lonneke van de Poll-Franse (Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands) W Wendy W. T. Lam (School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China) C Carolyn Taylor N Nicole L. Stout (Department of Survivorship and Wellness, American Cancer Society, Atlanta, GA) L Larissa Nekhlyudov (Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 08, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (8)

M

Michael Jefford

Australian Cancer Survivorship Centre, Centre for Health Services Research in Cancer, and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

R

Raymond Javan Chan

Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, SA, Australia

I

Ines Vaz-Luis

Cancer Survivorship, INSERM Unité 981, Institut Gustave Roussy, Villejuif, France

L

Lonneke van de Poll-Franse

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

W

Wendy W. T. Lam

School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

C

Carolyn Taylor

N

Nicole L. Stout

Department of Survivorship and Wellness, American Cancer Society, Atlanta, GA

L

Larissa Nekhlyudov

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001